Clinical Trials Browser

Phase EARLY_PHASE1 × Completed × gallium Ga 68 dotatate × Clear all

NCT01873248 2024-07-19

Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective

Phase EARLY_PHASE1 Completed

Neuroendocrine Tumors

NCT03197012 2020-07-07

Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor

Phase EARLY_PHASE1 Completed

Neuroendocrine Tumors